Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
03/2006
03/16/2006US20060058330 Rylene derivatives and their use as dyes
03/16/2006US20060058316 Side effect reduction; asthma; antiinflammatory agent; cognition enhancers; 2-{3'-[3-[(Cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-1-biphenyl-4-yl}cyclopropanecarboxylic acid
03/16/2006US20060058264 (2S,4aS,6aR,7R,9S,10aS,10bR)-9-(hydroxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester, for treating pain, drug or alcohol addiction; side effect reduction
03/16/2006CA2579378A1 Treatment of diseases using nalmefene and its analogs
03/16/2006CA2579204A1 Carbamoyl-substituted spiro derivative
03/16/2006CA2578933A1 Phenanthridine carbonyl phenols as cytokine modulators
03/15/2006EP1634596A1 Aporphine and oxoaporphine and the medical use thereof
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006EP1309593B1 Substituted pyrazoles
03/15/2006EP1020446B1 Naphthalimidobenzamide derivatives
03/15/2006EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
03/15/2006CN1245387C Use of 5-oxy-aporphine alkaloids in making hepatitis virus inhibiting activity drug
03/14/2006US7012141 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor nad acceptor dyes linked together
03/14/2006US7011701 n-heterocyclic anthracene-10-one compound
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/09/2006WO2006026531A1 Solvent free amorphous rapamycin
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006US20060052608 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052589 Colorant compounds containing copolymerizable vinyl groups
03/09/2006US20060052411 Immunosuppressants, analgesics, antiinflammatory agents
03/09/2006US20060051791 Methods of labelling polynucleotides with dibenzorhodamine dyes
03/09/2006CA2578245A1 Solvent free amorphous rapamycin
03/09/2006CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
03/08/2006EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same.
03/08/2006EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
03/08/2006EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/08/2006EP0877735B1 Polycyclic compounds
03/08/2006CN1743330A Aspergillus fumigatus dardarin C analogue, and its synthesizing method and use
03/08/2006CN1743329A Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use
03/08/2006CN1743328A Hexahydro-pyrazino-pyridino-indole, and its systhesis and use
03/08/2006CN1743327A Indole alkaloid derivative, and its preparing method and use
03/08/2006CN1743326A Carboline carboxylate derivative, and its synthesizing method and use
03/08/2006CN1742724A Dehydro eleagnine derivative, its synthesizing method and use
03/08/2006CN1244582C Compound of quinolone carboxylic acid, preparation method and medicinal usage
03/08/2006CN1244562C Process of synthesis of a tricyclic ketone intermediate
03/02/2006WO2006023669A2 Process for the production of levorphanol and related compounds
03/02/2006WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
03/02/2006WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
03/02/2006WO2004052850A3 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
03/02/2006US20060046994 Process for preparing 3-oxo-4-aza-5-alpha-androstane-17-carboxylic acid
03/02/2006US20060046985 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors
03/02/2006CA2577528A1 Heterocyclic antiviral compounds
03/02/2006CA2577406A1 Process for the production of levorphanol and related compounds
03/01/2006EP1628977A2 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
03/01/2006EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors
03/01/2006CN1740175A Plumepoppy total alkaloid salt and its prepn and application
03/01/2006CN1740161A Gabapentin hydrochloride preparing process
03/01/2006CN1740160A Synthesis process of loratadine intermediate
02/2006
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/23/2006WO2006019955A2 Antiviral methods and compositions
02/23/2006WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
02/23/2006US20060041134 Silyl ethers
02/23/2006US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
02/23/2006US20060040900 R(-)-10-methoxy-11-O-acetyl-N-n-propyl-noraporphine; Parkinson's disease, sexual dysfunction, and depressive disorders
02/22/2006EP1224187B1 Certain alkylene diamine-substituted heterocycles
02/22/2006CN1738824A CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
02/22/2006CN1738820A Novel diazabicyclic aryl derivatives
02/22/2006CN1738819A 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
02/22/2006CN1738816A Substituted indolepyridinium as anti-infective compounds
02/22/2006CN1738806A Oxo-azabicyclic compounds
02/22/2006CN1738803A Process for the preparation of aryl fused polycyclic lactams
02/22/2006CN1242991C Aporphine esters and their use in therapy
02/21/2006US7002016 reacting 1-(phenylglyoxylyl)piperidine arenesulfonylhydrazone in dichloromethane or toluene with base and phase transfer catalyst, to form (R*,R*)-enriched 7-phenyl-1-azabicyclo[4.2.0]octan-8-one; ring opening with methanol and hydrochloric acid
02/16/2006WO2006017542A1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
02/16/2006US20060036095 Colorant compounds
02/16/2006CA2575736A1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
02/16/2006CA2575582A1 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc.
02/15/2006EP1626050A1 Sulfur-containing naphthoylimide derivatives
02/15/2006CN1735620A Pure levofloxacin hemihydrate and processes for preparation thereof
02/15/2006CN1735613A 稠合杂环化合物 Fused heterocyclic compounds
02/15/2006CN1733769A Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses
02/15/2006CN1733764A 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy
02/15/2006CN1733733A Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug
02/15/2006CN1733732A Method for separating and purifying novel alkali B of cohosh root
02/15/2006CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
02/15/2006CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate
02/15/2006CN1241923C Method for extracting total alkaloid of corydalis rhizome and its new usage
02/14/2006US6998493 Colorant compounds
02/14/2006US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
02/14/2006CA2135926C Substituted hexahydrobenzo[a]phenanthridines
02/09/2006US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
02/09/2006US20060030565 Amide derivatives and nociceptin antagonists
02/09/2006US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006CN1732170A Fungicides
02/08/2006CN1732163A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/08/2006CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/08/2006CN1240701C 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists
02/07/2006US6995266 Thermally stable anthrapyridone compositions
02/07/2006US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
02/07/2006US6995167 Arylkylamine spirofuropyridines useful in therapy
02/02/2006WO2005118540A3 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
02/02/2006WO2005105753A3 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
02/02/2006US20060025595 Synthesis of indenoisoquinolines
02/02/2006US20060025436 Enantioselective preparation; ligands for the estrogen receptor; to prevent chronic inflammatory diseases without stimulating uterine and breast cell proliferation; 4-{[(6S)-8-Fluoro-6-methylphenanthridin-5(6H)-yl]sulfonyl}phenyl sulfamate
02/01/2006CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
02/01/2006CN1239503C Liquid crystalline-3, 4:9, 10-perylenetetracarboxylic acid diimides
01/2006
01/31/2006US6992088 Tetracyclic or pentacyclic cytotoxic agents, enzyme inhibitors, anticarcinogenic agents, bactericides, fungicides
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 110